MedTrace Logo

Efficacy and Acceptability of Low-Residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy

NCT01665157 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2014-04-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the efficacy and the acceptability of low-residue diet package (Enimaclin®) as diet control before colonoscopy.

Conditions

  • Dietary Modification

Interventions

DIETARY_SUPPLEMENT

Enimaclin®

Enimaclin Colomil ® (Glico Co., Japan Osaka)，a low-residue diet package for each meal. The duration of study is one day before colonoscopy.

OTHER

Self-controlled diet

Self-controlled low residue diet.

DRUG

2L PEG-ELS

Normal volume of PEG-ELS

DRUG

low volume 1.5L PEG-ELS

Low volume PEG-ELS

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Han-Mo Chiu, M.D., Ph.D. · NTUH

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01665157 on ClinicalTrials.gov